This study is in progress, not accepting new patients
Efficacy and Safety Trial of ADU-S100 and Pembrolizumab in Head and Neck Cancer
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at La Jolla, California and other locations
- Dates
- study startedestimated completion
Description
Summary
Official Title
Keywords
Eligibility
Locations
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Chinook Therapeutics, Inc.
- ID
- NCT03937141
- Phase
- Phase 2
- Study Type
- Interventional
- Last Updated